Published

Neuralink Gains Canadian Approval for Brain Implant Clinical Trials

  • Neuralink has received approval from Health Canada to start its first clinical trial in Canada for a brain implant device.
  • The trial aims to help people with quadriplegia use digital devices through thought control.
  • Toronto Western Hospital will host the trial, which will be the only site in Canada, as announced by UHN CEO Kevin Smith.
Insights by Ground AI
Does this summary seem wrong?
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center
50% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)